LH GI Oncology SRL
LH GI Oncology reported total assets of 26,616 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026).
The score of LH GI Oncology shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LH GI Oncology's annual accounts
| 2025 | |
|---|---|
| Net result | 19,097 € |
| Equity | 21,097 € |
| Cash | 23,050 € |
| EBITDA | 24,899 € |
| Total assets | 26,616 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
LH GI Oncology's financial analysis
- Solvency79.3%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LH GI Oncology
LH GI Oncology's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1020.786.527
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:1020786527 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Mar 2025
- Registered office
- 2800 Mechelen
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
LH GI Oncology (SRL) has been based in Mechelen since 2025, active in: medical specialists activities. For 2025, it reports a net profit of 19,097 € and equity of 21,097 €; its revenue is not published. Its solvency stands at 79.3%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to LH GI Oncology
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about LH GI Oncology
What is the revenue of LH GI Oncology?
LH GI Oncology files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LH GI Oncology?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for LH GI Oncology. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE1020786527. Its company number (CBE) is 1020.786.527.
Where is the registered office of LH GI Oncology?
According to the CBE register, the registered office of LH GI Oncology is in 2800 Mechelen.
What is the equity of LH GI Oncology?
At the close of the 2025 financial year, the equity of LH GI Oncology amounts to 21,097 €, a solvency of 79.3% of total assets.
Who manages LH GI Oncology?
The register lists 1 active mandates at LH GI Oncology. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LH GI Oncology
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →